| Q39361889 | Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review |
| Q93039067 | Candidate Biomarkers for the Diagnosis of Transient Ischemic Attack: A Systematic Review |
| Q42650011 | Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis |
| Q30656033 | Direct Reading of Bona Fide Barcode Assays for Diagnostics with Smartphone Apps |
| Q35821518 | Elevated Serum Levels of NSE and S-100β Correlate with Increased Risk of Acute Cerebral Infarction in Asian Populations |
| Q58799486 | Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management |
| Q30277942 | Isoflurane Post-Treatment Improves Outcome after an Embolic Stroke in Rabbits |
| Q38874973 | Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B protein in carotid surgery |
| Q104577221 | Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment |
| Q35094550 | Systemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established? |
| Q58695791 | The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease |